Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Upholding a role for EMT in breast cancer metastasis

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Fsp1 and vimentin are not universal markers of EMT programs in the MMTV-PyMT breast cancer model.

References

  1. 1

    Fischer, K. R. et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527, 472–476 (2015)

    ADS  CAS  Article  Google Scholar 

  2. 2

    Tan, T. Z. et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol. Med. 6, 1279–1293 (2014)

    CAS  Article  Google Scholar 

  3. 3

    Ye, X. et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525, 256–260 (2015)

    ADS  CAS  Article  Google Scholar 

  4. 4

    Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21–45 (2016)

    CAS  Article  Google Scholar 

  5. 5

    Cano, A. et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76–83 (2000)

    CAS  Article  Google Scholar 

  6. 6

    Batlle, E. et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84–89 (2000)

    CAS  Article  Google Scholar 

  7. 7

    Comijn, J. et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001)

    CAS  Article  Google Scholar 

  8. 8

    Bolós, V. et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116, 499–511 (2003)

    Article  Google Scholar 

  9. 9

    Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927–939 (2004)

    CAS  Article  Google Scholar 

  10. 10

    Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580–584 (2013)

    ADS  CAS  Article  Google Scholar 

  11. 11

    Grande, M. T. et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat. Med. 21, 989–997 (2015)

    CAS  Article  Google Scholar 

  12. 12

    Ocaña, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709–724 (2012)

    Article  Google Scholar 

  13. 13

    Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725–736 (2012)

    CAS  Article  Google Scholar 

  14. 14

    Tran, H. D. et al. Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res. 74, 6330–6340 (2014)

    CAS  Article  Google Scholar 

  15. 15

    Beerling, E. et al. Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity. Cell Reports 14, 2281–2288 (2016)

    CAS  Article  Google Scholar 

  16. 16

    Okada, H., Danoff, T. M., Kalluri, R. & Neilson, E. G. Early role of Fsp1 in epithelial-mesenchymal transformation. Am. J. Physiol. 273, F563–F574 (1997)

    CAS  Article  Google Scholar 

  17. 17

    Österreicher, C. H. et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl Acad. Sci. USA 108, 308–313 (2011)

    ADS  Article  Google Scholar 

  18. 18

    Xue, C., Plieth, D., Venkov, C., Xu, C. & Neilson, E. G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 63, 3386–3394 (2003)

    CAS  PubMed  Google Scholar 

  19. 19

    Korpal, M. et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 17, 1101–1108 (2011)

    CAS  Article  Google Scholar 

  20. 20

    Ni, T. et al. Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer. Nat. Cell Biol. 18, 1221–1232 (2016)

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

X.Y. produced and analysed the experimental data; T.B., Y.K., G.D.L., M.A.N., B.Z.S., J.Y. and R.A.W. conceived and wrote the manuscript.

Corresponding author

Correspondence to Robert A. Weinberg.

Ethics declarations

Competing interests

R.A.W. is listed as an inventor on three patent applications filed by the Whitehead Institute for Biomedical Research relating to the formation of cancer stem cells through activation of an EMT program. US patent application number US 14/441,697 describes a method to use PKCa/FRA1 pathway inhibitors to target carcinoma cells that are identified by their increased expression of EMT-related genes. US patent application number US 15/307,657 describes a method to induce cancer stem cells to undergo EMT, rendering them amenable to conventional treatments. US patent application number US 14/065,311 describes methods for identifying compounds and compositions that target cancer stem cells, including cancer stem cells that have undergone EMT. R.A.W. is also listed as an inventor on two related patents that have been granted. US patent number US9212347 describes methods for preparing progenitor cells by inducing EMT. US patent number US9308238 describes methods and compounds for modulating and inducing EMT. R.A.W. is also a cofounder of Verastem Inc.

Extended data figures and tables

Extended Data Figure 1 Individual channels of the stained images shown in Fig. 1b, c.

ad, DAPI nuclear staining is shown in blue. Anti-cytokeratin staining is shown in grey. Snail-expressing cells are marked by anti-YFP staining in green (a, b). Anti-Zeb1 staining is shown in green (c, d). Anti-Fsp1 (a, c) and anti-Vim (b, d) staining are shown in red. Arrows indicate cytokeratin-positive tumour cells that express either the Snail (a, b) or the Zeb1 (c, d) EMT transcription factor but, at the same time, lack evident Fsp1 (a, c) or Vim (b, d) expression. Scale bars, 20 μm.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ye, X., Brabletz, T., Kang, Y. et al. Upholding a role for EMT in breast cancer metastasis. Nature 547, E1–E3 (2017). https://doi.org/10.1038/nature22816

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing